Publications

ComputerTalk for the Pharmacist July/August 2018

PHSI President Tim Kosty contributed to the July/August 2018 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Tim discusses the impact of the 21st Century Cures Act on electronically shared health information and the technology necessary to establish an interoperable system.

Click here to read Tim’s article entitled “Interoperability, FHIR, and Blockchain”. You can read full versions of current and past ComputerTalk issues at https://www.computertalk.com/issue-archive/.

Amazon Acquiring PillPack: Industry Perspectives

Pharmacy Practice News shares multiple perspectives on Amazon’s acquisition of PillPack.  PHSI President Tim Kosty contributes thoughts on the financial viability of multi-dose packaging by pharmacies.

Click here to read the entire article.

ComputerTalk for the Pharmacist May/June 2018

PHSI President Tim Kosty and Vice President Don Dietz contributed to the May/June 2018 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Don discuss in detail four recent proposed mergers in the healthcare market and examine their impact on the pharmacy market.

Click here to read Tim and Don’s article entitled “Merger Mania Accelerates”. You can read full versions of current and past ComputerTalk issues at https://www.computertalk.com/issue-archive/.

ComputerTalk for the Pharmacist January/February 2018

PHSI President Tim Kosty and Vice President Don Dietz contributed to the January/February 2018 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Don identify the expectations for 2018 including generic deflation and vertical integration through mergers and acquisitions.

Click here to read Tim and Don’s article entitled “2018 Expectations”. You can read full versions of current and past ComputerTalk issues at https://www.computertalk.com/issue-archive/.

ComputerTalk for the Pharmacist November/December 2017

PHSI President Tim Kosty and Vice President Don Dietz contributed to the November/December 2017 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Don identify a detailed list of the top 20 key pharmacy areas that would be opportunities for virtual reality training.

Click here to read Tim and Don’s article entitled “Training Support with a New Technology Solution”. You can read full versions of current and past ComputerTalk issues at http://www.computertalk.com/issue-archive.

ComputerTalk for the Pharmacist September/October 2017

PHSI President Tim Kosty and consultant Ann Johnson contributed to the September/October 2017 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Ann discuss the barriers that Amazon will likely face when entering the pharmacy market, as well as some areas of opportunity to become successful in the market.

Click here to read Tim and Ann’s article entitled “Amazon: Pharmacy Disrupter or Tough Going”. You can read full versions of current and past ComputerTalk issues at http://www.computertalk.com/issue-archive.

ComputerTalk for the Pharmacist July/August 2017

PHSI President Tim Kosty contributed to the July/August 2017 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Tim explores the historical issues with DUR system configurations and suggest steps the industry needs to take to improve patient safety.

Click here to read Tim’s article entitled “Drug Utilization Alerts: Failures and Future Direction”. You can read full versions of current and past ComputerTalk issues at http://www.computertalk.com/issues-archive.

ComputerTalk for the Pharmacist May/June 2017

PHSI Consultant Dave Schuetz contributed to the May/June 2017 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Dave discusses the concern that the NDC (National Drug Code) number is going to run out of numbers sometime in the next decade and the need for industry stakeholders to start the discussion and work toward a goal before it’s too late.

Click here to read Dave’s article entitled “What Happens When We Run Out of NDC Numbers?”

ComputerTalk for the Pharmacist January/February 2017

PHSI President Tim Kosty and Vice President Don Dietz contributed to the January/February 2017 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Don provide a forecast of market changes for 2017. The article reviews topics related to industry challenges, preferred pharmacy networks, driving pharmacy efficiency, clinical services, and industry consolidation.

Click here to read their article entitled “The Outlook for 2017”.

Conflicts with Value-Based Medication Pricing

With multiple diverse variables and stakeholders to consider, controlling healthcare expenditures has proven to be a difficult problem to solve. Recently, the American Medical Association has voiced support for Value-Based Medication Pricing. This means that a drug would be priced based on the benefit to the patient’s care. While this may seem like a promising strategy, there are several concerns that arise under value-based pricing. For instance, generic drugs often provide high levels of care but do not fall under high price brackets. Under a value-based system, would the prices increase to reflect the value of a low-cost antibiotic? Also, many nonessential prescription products do not make it onto an insurance formulary, including various topical products that are mostly used for cosmetic purposes. This means that the value is much more personal to the patient. The ambiguity in value makes it extremely difficult to establish a value-based price.  In value-based pricing, the payer is the stakeholder defining value.  Another concern that is often brought up when discussing drug costs is research and development.  Often, profits in pharmaceutical manufacturing are used to fund research and development for new innovative medications. Many fear that drastically changing the way medications are priced could hinder new drugs coming to market. Time will tell if value-based pricing attracts more attention but both arguments highlight the fact that coming up with a strategy to price medications is no easy task.

 

http://insidepatientcare.com/issues/2016/december-2016-vol-4-no-12/449-value-based-medication-pricing